Schroder Investment Management Group
PRVA icon

Schroder Investment Management Group’s Privia Health PRVA Stock Holding History

Schroder Investment Management Group’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.6M Sell
140,738
-2,381
-2% -$55.2K ﹤0.01% 826
2026
Q1 		$2.87M Buy
143,119
+3,081
+2% +$69.4K ﹤0.01% 865
2025
Q4 		$3.34M Buy
140,038
+1,123
+0.8% +$27.3K ﹤0.01% 817
2025
Q3 		$3.39M Sell
138,915
-1,683
-1% -$36.2K ﹤0.01% 837
2025
Q2 		$3.09M Sell
140,598
-60,685
-30% -$1.41M ﹤0.01% 844
2025
Q1 		$4.55M Sell
201,283
-9,550
-5% -$222K ﹤0.01% 774
2024
Q4 		$4.1M Buy
210,833
+5,326
+3% +$106K ﹤0.01% 808
2024
Q3 		$3.72M Buy
205,507
+968
+0.5% +$18.5K ﹤0.01% 845
2024
Q2 		$3.55M Sell
204,539
-1,478
-0.7% -$26.2K ﹤0.01% 842
2024
Q1 		$4.04M Sell
206,017
-40,722
-17% -$860K ﹤0.01% 815
2023
Q4 		$5.68M Sell
246,739
-27,728
-10% -$621K 0.01% 740
2023
Q3 		$6.31M Sell
274,467
-21,959
-7% -$558K 0.01% 694
2023
Q2 		$7.74M Hold
296,426
– – 0.01% 689
2023
Q1 		$8.18M Buy
296,426
+66,611
+29% +$1.76M 0.01% 676
2022
Q4 		$5.22M Sell
229,815
-78,170
-25% -$2.18M 0.01% 769
2022
Q3 		$10.5M Sell
307,985
-190,217
-38% -$7.03M 0.02% 601
2022
Q2 		$14.5M Buy
498,202
+51,232
+11% +$1.3M 0.02% 556
2022
Q1 		$12.2M Buy
446,970
+325,932
+269% +$7.7M 0.02% 626
2021
Q4 		$3.13M Buy
121,038
+16,881
+16% +$421K ﹤0.01% 846
2021
Q3 		$2.45M Sell
104,157
-99,143
-49% -$3.46M ﹤0.01% 935
2021
Q2 		$9.02M Buy
+203,300
New +$7.5M 0.01% 703

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Schroder Investment Management Group's PRVA Position: Q2 2026 in Review

Schroder Investment Management Group reduced its Privia Health (PRVA) stake by 1.7% in Q2 2026, selling an estimated $55.2K and leaving 140,738 shares worth $3.6M. The position accounts for ﹤0.01% of the portfolio, ranked #826.

Schroder Investment Management Group first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $14.5M in Q2 2022. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Schroder Investment Management Group held 140,738 shares of Privia Health worth $3.6M as of Q2 2026.
  • Schroder Investment Management Group sold 2,381 Privia Health shares in Q2 2026, an estimated $55.2K.
  • Privia Health made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #826 holding.
  • Schroder Investment Management Group first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Schroder Investment Management Group's Privia Health position peaked at $14.5M in Q2 2022.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.